Medanta Advances Cataract Surgery with UNITY VCS System

Medanta Advances Cataract Surgery with UNITY VCS System

India Pharma Outlook Team | Thursday, 30 October 2025

 Medanta, UNITY VCS

Medanta, one of India’s leading super-specialty healthcare providers, has taken a major step in advancing eye care with the launch of the UNITY Vitreoretinal Cataract System (VCS) at Medanta Mediclinic, Defence Colony, New Delhi.

The hospital is the first in the country to implement this next-generation surgical system, designed to offer precision-driven and patient-centric ophthalmic care.

The UNITY VCS system marks a breakthrough in cataract and vitreoretinal surgery. It combines intelligent fluidics, real-time sensing, and several first-to-market innovations to enhance surgical precision, safety, and efficiency.

Also Read: India's Path to Billion-Dollar Drugs: Building a Strong Ecosystem

Dr. Sudipto Pakrasi, chairman, ophthalmology, Medanta – The Medicity, said: “Eye diseases such as cataract, diabetic retinopathy, and retinal disorders continue to affect millions across India. The country has an estimated 4.95 million blind persons and nearly 70 million people with vision impairment, with 6–7 million cataract surgeries performed annually. Despite having around 25,000 ophthalmologists, just about 15 per million population, the demand for advanced and efficient surgical care continues to grow.  

Dr Naresh Trehan, chairman and managing director, Medanta, said, “Our  mission is to deliver world-class health care services, and the new cataract system further strengthens our aim towards that objective. At the heart of everything we do is the patient, empowered by our pursuit of excellence in infrastructure, technology, talent, and trust, while our doctors rank among the finest in their respective fields, placing Medanta on par with global leaders in medical care.”

Its UNITY 4D Phaco technology allows 2X faster nucleus removal using 41% less energy, leading to 50% quicker outcomes. The HYPERVIT 30K Vitrectomy Probe, the world’s fastest, ensures exceptional precision with minimal retinal traction. Features like UNITY Intelligent Fluidics maintain stable intraocular pressure, while Thermal Sentry prevents tissue damage by monitoring incision temperature.

on the deck

Most Viewed

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.